Billy Candra 
admin 
Budi Oetomo Narendra 
Hendra Lukman 
Gilang Cahya A Revolutionary Nanoparticle Platform Offers New Hope in the Fight Against Glioblastoma
Nana O Glioblastoma, the most aggressive form of brain cancer, presents a formidable challenge to medical science....
University of Oklahoma Researchers Uncover How Aggressive Breast Cancer Hijacks Immune System to Promote Nerve Growth, Opening New Therapeutic Avenues
New research from the University of Oklahoma (OU) has delivered a significant breakthrough in understanding...
New Experimental Drug CS18 Targets Cancer’s ‘Switchboard’ to Combat Treatment Resistance, Baylor Study Reveals
Researchers at Baylor College of Medicine have announced the development of an experimental drug, CS18,...
Colorectal Cancer Emerges as Leading Cause of Cancer Death in Adults Under 50, Prompting Urgent Public Health Call to Action
Colorectal cancer has become the leading cause of cancer-related death among people younger than 50....
Revolutionary TCR Therapy Platform Promises Accessible, Off-the-Shelf Cancer Treatments
Lina carolina T cell receptor (TCR) therapy represents a groundbreaking frontier in oncology, offering a highly precise...
Barzolvolimab Shows Unprecedented Efficacy in Chronic Hives but Raises Safety Questions with Anaphylaxis Cases
Celldex Therapeutics’ experimental drug, barzolvolimab, has presented a complex picture to the biopharmaceutical world, demonstrating...
Oregon State University Researchers Develop Innovative Sugar-Coated Nanoparticle Delivery System to Combat Aggressive Glioblastoma Brain Tumors
Gabriel Paijo In a significant advancement for neuro-oncology, a multidisciplinary team of researchers at Oregon State University...
Shingles Vaccine Linked to Significantly Lower Dementia Risk in Landmark Welsh Study
An unprecedented examination of health records from Wales has provided some of the most compelling...
Breakthrough in Polycystic Kidney Disease Research UC Santa Barbara Scientists Develop Targeted Antibody Therapy to Disrupt Cyst Growth
George Ongkojoyo In a significant advancement for renal medicine, researchers at the University of California, Santa Barbara...
FDA Grants Accelerated Approval to OJEMDA as First Targeted Therapy for BRAF-Altered Pediatric Low-Grade Glioma
The U.S. Food and Drug Administration (FDA) has officially granted accelerated approval to OJEMDA (tovorafenib),...
